Pieris Pharmaceuticals, Inc. Gains 103.24%

Tue, May 25, 2021 at 05:30 PM
Pieris Pharmaceuticals, Inc. Gains 103.24%

Pieris Pharmaceuticals, Inc. (PIRS:NASDAQ) rocketted at $3.76, representing a gain of 103.2%. On Mon, May 24, 2021, PIRS:NASDAQ hit a New 2-Week Intraday High of $1.96. The stock appeared on our News Catalysts scanner on Tue, May 25, 2021 at 02:36 PM in the 'PATNERSHIP' category. From Mon, May 10, 2021, the stock recorded 60.00% Up Days and 63.64% Green Days

The stock spiked on Wed, Feb 10, 2021 at $3.45 with a volume of 1M+, and its share price has been moving sideways in recent weeks.

About Pieris Pharmaceuticals, Inc. (PIRS:NASDAQ)

Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in discovering and developing Anticalin class of biotherapeutics for patients with diseases in which there is high unmet medical needs.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.